Assessment of the Performance of Magnetic Resonance Imaging/Ultrasound Fusion Guided Prostate Biopsy against a Combined Targeted Plus Systematic Biopsy Approach Using 24-Core Transperineal Template Saturation Mapping Prostate Biopsy

Table 2

PI-RADS score and cancer detection rates ().

PI-RADS	Frequency	MRI-fusion biopsy
		All PCa	Sig PCa
1/2	28	4 (14%)	2 (7%)
3	80	30 (38%)	17 (21%)
4	55	38 (69%)	33 (60%)
5	22	20 (91%)	18 (82%)
Total	185	92	70

PCa = prostate cancer, Sig = significant.
Due to clinical reasons these patients with PI-RADS 1/2 ROIs underwent targeted biopsy.